Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Cash from Investing Activities (2017 - 2025)

Skinvisible's Cash from Investing Activities history spans 14 years, with the latest figure at $1.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities changed N/A year-over-year to $1.0; the TTM value through Sep 2025 reached $1.0, up 100.01%, while the annual FY2024 figure was -$9218.0, 1.23% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was $1.0 at Skinvisible, roughly flat from $1.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1.0 in Q3 2023 and bottomed at -$20414.0 in Q2 2021.
  • The 4-year median for Cash from Investing Activities is -$525.0 (2022), against an average of -$4388.7.
  • The largest YoY upside for Cash from Investing Activities was 48.28% in 2021 against a maximum downside of 47.9% in 2021.
  • A 4-year view of Cash from Investing Activities shows it stood at -$20414.0 in 2021, then surged by 97.43% to -$525.0 in 2022, then soared by 100.19% to $1.0 in 2023, then changed by 0.0% to $1.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Cash from Investing Activities are $1.0 (Q3 2025), $1.0 (Q3 2023), and -$8809.0 (Q2 2023).